Sandra E. Peterson
Lead Independent DirectorMs. Sandra E. Peterson, also known as Sandi, is Lead Independent Director of Microsoft Corporation from March 2023. She joined the Microsoft Corporation on December 02, 2015. She is Independent Director of Microsoft Corporation from December 02, 2015 to March 2023. She is Operating Partner of Clayton, Dubilier & Rice, LLC. She joined the Clayton, Dubilier & Rice, LLC in 2019. She focuses on Healthcare, Consumer, North America and Europe. She was Partner of Clayton, Dubilier & Rice, LLC. She was Operating Partner of Clayton, Dubilier & Rice, LLC from April 29, 2019. She is Chairman of Cynosure, LLC from December 2019. She is Chairman of M2Gen, Corp. from March 17, 2021. She is Member of Temasek Americas Advisory Panel of Temasek Holdings (Private) Limited. She is Member of International Advisory Board of Hakluyt & Company Limited. She served as an Independent Director of Covetrus, Inc. from June 2020. She joined the Covetrus, Inc. in June 2020. She is Director of Volastra Therapeutics, Inc. She is Chairman of the Board of M2Gen Holdings, L.P. She is an Independent Non-Employee Director of Seaport Therapeutics, Inc. from November 2024. She was Group President of Government - Medco Health of Medco Health Solutions, Inc. She joined the Medco Health Solutions, Inc. in December 1998. She was Executive VP & Group Worldwide Chairman of Johnson & Johnson from April 2016 to October 01, 2018. She was Group Worldwide Chairman of Johnson & Johnson. She was employed at Johnson & Johnson from 2012 to October 01, 2018. She was Chairman of Management Board for Bayer Cropscience and CEO of Bayer Cropscience of Bayer Aktiengesellschaft. She was employed at Bayer Aktiengesellschaft from October 01, 2010 to October 01, 2010. She was Independent Director of Handleman Company. She was employed at Handleman Company from 2001 to November 16, 2005. She was Director of Dun & Bradstreet, Inc. She was employed at Dun & Bradstreet, Inc. from September 2002 to October 22, 2015. She was President of Diabetes Care Division of Bayer HealthCare LLC. She was President of the Diabetes Care Division of Bayer HealthCare AG. She joined the Bayer HealthCare AG on May 10, 2005. She was Lead Independent Director of Zymergen Inc. from August 02, 2021 to October 18, 2022. She was Independent Director of Zymergen Inc. from December 2019 to August 02, 2021. She was employed at Zymergen Inc. until October 18, 2022. She was Chief Executive Officer of Bayer Cropscience of Nunhems B.V. She was Chairwoman of the Board of Management and Chief Executive Officer of Bayer CropScience Aktiengesellschaft. She was employed at Bayer CropScience Aktiengesellschaft from January 2009 to November 2012. She has B.A. in Government from Cornell University, M.P.A. in Applied Economics from Princeton University.
Positions
- Company NameMicrosoft CorporationStock CodeMSFTPositionLead Independent DirectorColleagues
- Company NameSeaport Therapeutics, Inc.Stock CodeSPTXPositionIndependent Non-Employee DirectorColleagues
- SMSteven M. PaulFounder & Non-Employee Chair of the Board
- DZDaphne ZoharFounder, CEO, President & Director
- MCMichael Cunyuan ChenCo-Founder & Chief Scientific Officer
- ALAntony LoebelChief Medical Officer & President of Clinical Development
- LALauren A. WhiteChief Financial Officer
- DMDenice M. TorresLead Independent Non-Employee Director
- SESandra E. PetersonIndependent Non-Employee Director
- RJRobert J. HombachIndependent Non-Employee Director
